speb/financial-data huggingface dataset:
DR.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 9204000.00
DR.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 68598000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 68598000.00
DR.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 6006000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 1093000.00
DR.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 6006000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 1093000.00
DR.TO cash_flow (annual, 2025-12-31) — Depreciation: 15124000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 3350000.00
DR.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 15664000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3486000.00
DR.TO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 11730000.00
DR.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: -448000.00
DR.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 15664000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 3486000.00
DR.TO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 11730000.00
DR.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: -448000.00
DR.TO income_statement (annual, 2025-12-31) — Depreciation Income Statement: 11190000.00
DR.TO income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: -584000.00
DR.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 19481353.00
DR.TO income_statement (annual, 2025-12-31) — Diluted EPS: 1.09
DR.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 21256000.00
DR.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 4255000.00
DR.TO balance_sheet (annual, 2025-12-31) — Dividends Payable: 1172000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 1172000.00
DR.TO income_statement (annual, 2025-12-31) — EBIT: 48524000.00
DR.TO income_statement (quarterly, 2025-12-31) — EBIT: 5443000.00
DR.TO income_statement (annual, 2025-12-31) — EBITDA: 64188000.00
DR.TO income_statement (quarterly, 2025-12-31) — EBITDA: 8929000.00
DR.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -165000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 12000.00
DR.TO cash_flow (annual, 2025-12-31) — End Cash Position: 43449000.00
DR.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 43449000.00
DR.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -105454000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -15900000.00
DR.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 40282000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 12233000.00
DR.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
DR.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -165000.00
DR.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 12000.00
DR.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 119230000.00
DR.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 6572000.00
DR.TO balance_sheet (annual, 2025-12-31) — Goodwill: 75853000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 75853000.00
DR.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 79850000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 79850000.00
DR.TO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 36130000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 36130000.00
DR.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 103814000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 103814000.00
DR.TO income_statement (annual, 2025-12-31) — Gross Profit: 177618000.00
DR.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 15638000.00
DR.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 304000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 304000.00
DR.TO income_statement (annual, 2025-12-31) — Interest Expense: 8936000.00
DR.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 2316000.00
DR.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 8936000.00
DR.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 2316000.00
DR.TO income_statement (annual, 2025-12-31) — Interest Income: 2206000.00
DR.TO income_statement (quarterly, 2025-12-31) — Interest Income: -4060000.00
DR.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 2206000.00
DR.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: -4060000.00
DR.TO cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -5011000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Cfo: -1700000.00
DR.TO balance_sheet (annual, 2025-12-31) — Inventory: 5834000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 5834000.00
DR.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 105752000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 105752000.00
DR.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -4067000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -984000.00
DR.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1029000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 1000.00
DR.TO balance_sheet (annual, 2025-12-31) — Land And Improvements: 9374000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 9374000.00
DR.TO balance_sheet (annual, 2025-12-31) — Leases: 18894000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Leases: 18894000.00
DR.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 22689000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 22689000.00
DR.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 26950000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 26950000.00
DR.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 49639000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 49639000.00
DR.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1029000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 1000.00
DR.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -15001000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -3373000.00
DR.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 30386000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 30386000.00
DR.TO balance_sheet (annual, 2025-12-31) — Minority Interest: 25101000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 25101000.00
DR.TO income_statement (annual, 2025-12-31) — Minority Interests: -23162000.00
DR.TO income_statement (quarterly, 2025-12-31) — Minority Interests: -8100000.00
DR.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 812000.00
DR.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -63662000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -5149000.00
DR.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 165000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -12000.00
DR.TO income_statement (annual, 2025-12-31) — Net Income: 21256000.00
DR.TO income_statement (quarterly, 2025-12-31) — Net Income: 4770000.00
DR.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 21256000.00
DR.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 4770000.00
DR.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 34615000.00
DR.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 3067000.00
DR.TO income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 9803000.00
DR.TO income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 9803000.00
DR.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 21256000.00
DR.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4770000.00
DR.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 11453000.00
DR.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -5033000.00
DR.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 44418000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 12870000.00
DR.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 44418000.00
DR.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 12870000.00
DR.TO income_statement (annual, 2025-12-31) — Net Interest Income: -6905000.00
DR.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -6399000.00
DR.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -13972000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -3372000.00
DR.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -13972000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -3372000.00
DR.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -6905000.00
DR.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -6399000.00
DR.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -22729000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -6194000.00
DR.TO balance_sheet (annual, 2025-12-31) — Net PPE: 70055000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 70055000.00
DR.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -4879000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1796000.00
DR.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -4394000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -4394000.00
DR.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 172000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 172000.00
DR.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 14299000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 14299000.00
DR.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 172000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 172000.00
DR.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 14299000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 14299000.00
DR.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 64353000.00
DR.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 8917000.00
DR.TO income_statement (annual, 2025-12-31) — Normalized Income: 11597272.89
DR.TO income_statement (quarterly, 2025-12-31) — Normalized Income: -5044769.75
DR.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 45161000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 14029000.00
DR.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 165000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -12000.00
DR.TO income_statement (annual, 2025-12-31) — Operating Income: 46658000.00
DR.TO income_statement (quarterly, 2025-12-31) — Operating Income: 9514000.00
DR.TO income_statement (annual, 2025-12-31) — Operating Revenue: 254166000.00
DR.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 9334000.00
DR.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 17868649.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 17868649.00
DR.TO cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: -522000.00
DR.TO balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 3346000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 3346000.00
DR.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 27184000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 27184000.00
DR.TO income_statement (annual, 2025-12-31) — Other Gand A: 49850000.00
DR.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 6225000.00
DR.TO income_statement (annual, 2025-12-31) — Other Income Expense: -165000.00
DR.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 12000.00
DR.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 3997000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 3997000.00
DR.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 7118000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 6674000.00
DR.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 39542000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 39542000.00
DR.TO balance_sheet (annual, 2025-12-31) — Other Properties: 2906000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 2906000.00
DR.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 3903000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 3903000.00
DR.TO balance_sheet (annual, 2025-12-31) — Payables: 16845000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Payables: 16845000.00
DR.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 32210000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 32210000.00
DR.TO income_statement (annual, 2025-12-31) — Pretax Income: 39588000.00
DR.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 3127000.00
DR.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
DR.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -4879000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1796000.00
DR.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 5834000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 5834000.00
DR.TO balance_sheet (annual, 2025-12-31) — Receivables: 39224000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 39224000.00
DR.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 72614000.00
DR.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: -6304000.00
DR.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 15664000.00
DR.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 3486000.00
DR.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -15001000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -3373000.00
DR.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -63662000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -5149000.00
DR.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: -178944000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -178944000.00
DR.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 69380000.00
DR.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 347000.00
DR.TO cash_flow (annual, 2025-12-31) — Sale Of Business: 812000.00
DR.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 119230000.00
DR.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 6572000.00
DR.TO balance_sheet (annual, 2025-12-31) — Share Issued: 17868649.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 17868649.00
DR.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 0.00
DR.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 0.00
DR.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 75456000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 75456000.00
DR.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: -4394000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -4394000.00
DR.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -20727.11
DR.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 230.25
DR.TO income_statement (annual, 2025-12-31) — Tax Provision: 4973000.00
DR.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 60000.00
DR.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.13
DR.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.02
DR.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 240000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 240000.00
DR.TO cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -19308000.00
DR.TO cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -1213000.00
DR.TO balance_sheet (annual, 2025-12-31) — Total Assets: 272635000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 272635000.00
DR.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 102406000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 102406000.00
DR.TO balance_sheet (annual, 2025-12-31) — Total Debt: 58843000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 58843000.00
DR.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 100557000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 100557000.00
DR.TO income_statement (annual, 2025-12-31) — Total Expenses: 207508000.00
DR.TO income_statement (quarterly, 2025-12-31) — Total Expenses: -180000.00
DR.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 172078000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 172078000.00
DR.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 150077000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 150077000.00
DR.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 103480000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 103480000.00
DR.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 46658000.00
DR.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 9514000.00
DR.TO income_statement (annual, 2025-12-31) — Total Other Finance Cost: 175000.00
DR.TO income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 23000.00
DR.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 304000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 304000.00
DR.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -165000.00
DR.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 12000.00
DR.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -165000.00
DR.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 12000.00
DR.TO balance_sheet (annual, 2025-12-31) — Working Capital: 53960000.00
DR.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 53960000.00
DR.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 33956000.00
DR.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 67110000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 13602000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 32684000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 470000.00
DR.TO income_statement (quarterly, 2026-03-31) — Amortization: 133000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 133000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 133000.00
DR.TO income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 133000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
DR.TO income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: -3527000.00
DR.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 17704457.00
DR.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 1.40
DR.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 43449000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1201000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 27455000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 251678000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 86302000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 86302000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -1172000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -14787000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 42870000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 14135000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -952000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -1795000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -375000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: -952000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -2747000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 222000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 3398000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 498000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 3398000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 42218000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 251678000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -1172000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 96801000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -3871000.00
DR.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 20769000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 14395000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 128982000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 5925000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 3393000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 9318000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 61919000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 4315000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 4315000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Depreciation: 2792000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 2925000.00
DR.TO income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 2925000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 2925000.00
DR.TO income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 2925000.00
DR.TO income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 2792000.00
DR.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 20775059.00
DR.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.02
DR.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 21205000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 1135000.00
DR.TO income_statement (quarterly, 2026-03-31) — EBIT: 19971000.00
DR.TO income_statement (quarterly, 2026-03-31) — EBITDA: 22896000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 52000.00
DR.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 86302000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -14787000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 12934000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: -16825000.00
DR.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 52000.00
DR.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 31031000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 75853000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 79717000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 68918000.00
DR.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 46341000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 9059000.00
DR.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 2509000.00
DR.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2509000.00
DR.TO income_statement (quarterly, 2026-03-31) — Interest Income: 7568000.00
DR.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 7568000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Cfo: -1520000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 6214000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 126546000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 42870000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 21530000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 26352000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 47882000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -3909000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Minority Interest: 20595000.00
DR.TO income_statement (quarterly, 2026-03-31) — Minority Interests: -5217000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 43930000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -3871000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -52000.00
DR.TO income_statement (quarterly, 2026-03-31) — Net Income: 24732000.00
DR.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 24732000.00
DR.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 13133000.00
DR.TO income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 16816000.00
DR.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 24732000.00
DR.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 7916000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 29949000.00
DR.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 29949000.00
DR.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: 5025000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 141000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -3909000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -3909000.00
DR.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 5025000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -5835000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 68918000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1201000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 17084000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 220000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 18023000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 220000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 18023000.00
DR.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 22844000.00
DR.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 7876891.31
DR.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 14135000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -16877000.00
DR.TO income_statement (quarterly, 2026-03-31) — Operating Income: 12385000.00
DR.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 67110000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 17550249.00
DR.TO cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 583000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 3393000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 14410000.00
DR.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 13214000.00
DR.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 52000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 3864000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -4997000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 32617000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 68918000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 3324000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Payables: 23796000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 38191000.00
DR.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 17462000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1201000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 6214000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 36466000.00
DR.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 20769000.00
DR.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 2925000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -3909000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -3871000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -155347000.00
DR.TO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 17817000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Sale Of Business: 43930000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 141000.00
DR.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 31031000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 17550249.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 96801000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 17084000.00
DR.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 12891.31
DR.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 4329000.00
DR.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
DR.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 458000.00
DR.TO cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -158000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 277837000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 123153000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 57200000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 117396000.00
DR.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 54725000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 160441000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 148855000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 98522000.00
DR.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 12385000.00
DR.TO income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 34000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 9059000.00
DR.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 52000.00
DR.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 52000.00
DR.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 67063000.00
DR0.DE cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -18092902.00
DR0.DE income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
DR0.DE cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: 1.00
DR0.DE income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -3157413.00
DR0.DE balance_sheet (annual, 2021-12-31) — Other Properties: 295749463.00
DR0.DE balance_sheet (annual, 2021-12-31) — Other Receivables: 1103287.00
DR0.DE income_statement (annual, 2021-12-31) — Rent And Landing Fees: 284671.00
DR0.DE income_statement (annual, 2021-12-31) — Rent Expense Supplemental: 284671.00
DR0.DE cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
DR0.DE cash_flow (annual, 2021-12-31) — Taxes Refund Paid: 0.00
DR0.DE balance_sheet (annual, 2021-12-31) — Treasury Shares Number: 128223.00
DR0.DE income_statement (annual, 2022-12-31) — +Operating Expense: 12251473.00
DR0.DE income_statement (annual, 2022-12-31) — +Total Revenue: 165439266.00
DR0.DE balance_sheet (annual, 2022-12-31) — Accounts Payable: 11375562.00
DR0.DE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 28649496.00
DR0.DE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -197316765.00
DR0.DE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 31250251.00
DR0.DE balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 12047919.00
DR0.DE income_statement (annual, 2022-12-31) — Basic Average Shares: 5001316.00
DR0.DE income_statement (annual, 2022-12-31) — Basic EPS: 12.15
DR0.DE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 11610709.00
DR0.DE cash_flow (annual, 2022-12-31) — Capital Expenditure: -88949545.00
DR0.DE balance_sheet (annual, 2022-12-31) — Capital Stock: 5003081.00
DR0.DE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 47479228.00
DR0.DE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 54195815.00
DR0.DE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -2665791.00
DR0.DE balance_sheet (annual, 2022-12-31) — Cash Financial: 47479228.00
DR0.DE cash_flow (annual, 2022-12-31) — Change In Inventory: -6679737.00
DR0.DE cash_flow (annual, 2022-12-31) — Change In Payable: 9206488.00
DR0.DE cash_flow (annual, 2022-12-31) — Change In Working Capital: 21409013.00
DR0.DE cash_flow (annual, 2022-12-31) — Changes In Cash: 35836161.00
DR0.DE balance_sheet (annual, 2022-12-31) — Common Stock: 5003081.00
DR0.DE cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -2665791.00
DR0.DE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 128961442.00
DR0.DE cash_flow (annual, 2022-12-31) — Common Stock Issuance: 186182.00
DR0.DE cash_flow (annual, 2022-12-31) — Common Stock Payments: -16358904.00
DR0.DE balance_sheet (annual, 2022-12-31) — Construction In Progress: 0.00
DR0.DE income_statement (annual, 2022-12-31) — Cost Of Revenue: 72284870.00
DR0.DE balance_sheet (annual, 2022-12-31) — Current Assets: 88805489.00
DR0.DE balance_sheet (annual, 2022-12-31) — Current Debt: 77096.00
DR0.DE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 77096.00
DR0.DE balance_sheet (annual, 2022-12-31) — Current Liabilities: 40301582.00
DR0.DE cash_flow (annual, 2022-12-31) — Deferred Tax: 23356202.00
DR0.DE cash_flow (annual, 2022-12-31) — Depreciation: 39790250.00
DR0.DE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 39790250.00
DR0.DE income_statement (annual, 2022-12-31) — Diluted Average Shares: 5001316.00
DR0.DE income_statement (annual, 2022-12-31) — Diluted EPS: 12.15
DR0.DE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 60765991.00
DR0.DE income_statement (annual, 2022-12-31) — EBIT: 92815946.00
DR0.DE income_statement (annual, 2022-12-31) — EBITDA: 132606196.00
DR0.DE cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -44738.00
DR0.DE cash_flow (annual, 2022-12-31) — End Cash Position: 47402131.00
DR0.DE cash_flow (annual, 2022-12-31) — Financing Cash Flow: -34731668.00
DR0.DE balance_sheet (annual, 2022-12-31) — Finished Goods: 129865.00
DR0.DE cash_flow (annual, 2022-12-31) — Free Cash Flow: 53782528.00
DR0.DE cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 1868384.00
DR0.DE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -8276628.00
DR0.DE income_statement (annual, 2022-12-31) — General And Administrative Expense: 5872802.00
DR0.DE balance_sheet (annual, 2022-12-31) — Goodwill: 1163358.00
DR0.DE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 33929482.00
DR0.DE balance_sheet (annual, 2022-12-31) — Gross PPE: 389956607.00
DR0.DE income_statement (annual, 2022-12-31) — Gross Profit: 93154396.00
DR0.DE income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: -2472222.00
DR0.DE income_statement (annual, 2022-12-31) — Interest Expense: 6877926.00
DR0.DE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 6877926.00
DR0.DE income_statement (annual, 2022-12-31) — Interest Income: 1384502.00
DR0.DE income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1384502.00
DR0.DE cash_flow (annual, 2022-12-31) — Interest Paid Cff: -6725238.00
DR0.DE cash_flow (annual, 2022-12-31) — Interest Received Cfi: 630721.00
DR0.DE balance_sheet (annual, 2022-12-31) — Inventory: 129865.00
DR0.DE balance_sheet (annual, 2022-12-31) — Invested Capital: 238853538.00
DR0.DE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -72164244.00
DR0.DE balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 12047919.00
DR0.DE cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 186182.00
DR0.DE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 21334379.00
DR0.DE balance_sheet (annual, 2022-12-31) — Long Term Debt: 109815000.00
DR0.DE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 109815000.00
DR0.DE cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 21334379.00
DR0.DE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -29438977.00
DR0.DE balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 15406652.00
DR0.DE balance_sheet (annual, 2022-12-31) — Long Term Provisions: 31634932.00
DR0.DE balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 357692303.00
DR0.DE balance_sheet (annual, 2022-12-31) — Minority Interest: 3403429.00
DR0.DE income_statement (annual, 2022-12-31) — Minority Interests: -5419614.00
DR0.DE cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -16172722.00
DR0.DE balance_sheet (annual, 2022-12-31) — Net Debt: 62412868.00
DR0.DE income_statement (annual, 2022-12-31) — Net Income: 60765991.00
DR0.DE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 60765991.00
DR0.DE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 66185606.00
DR0.DE income_statement (annual, 2022-12-31) — Net Income Extraordinary: 0.00
DR0.DE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 60765991.00
DR0.DE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 60765991.00
DR0.DE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 66185605.00
DR0.DE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 66185605.00
DR0.DE cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 455509.00
DR0.DE income_statement (annual, 2022-12-31) — Net Interest Income: -6877926.00
DR0.DE cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 9664578.00
DR0.DE cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -8104598.00
DR0.DE cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -8104598.00
DR0.DE income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -6877926.00
DR0.DE cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1.00
DR0.DE balance_sheet (annual, 2022-12-31) — Net PPE: 192639842.00
DR0.DE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -82915052.00
DR0.DE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 95031960.00
DR0.DE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 1008133.00
DR0.DE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 36210103.00
DR0.DE income_statement (annual, 2022-12-31) — Normalized EBITDA: 124624855.00
DR0.DE income_statement (annual, 2022-12-31) — Normalized Income: 54619120.37
DR0.DE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 142732073.00
DR0.DE income_statement (annual, 2022-12-31) — Operating Income: 80902923.00
DR0.DE income_statement (annual, 2022-12-31) — Operating Revenue: 165439266.00
DR0.DE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 5003081.00
DR0.DE cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: -1.00
DR0.DE balance_sheet (annual, 2022-12-31) — Other Current Assets: 4884252.00
DR0.DE balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 27423138.00
DR0.DE balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 32766124.00
DR0.DE cash_flow (annual, 2022-12-31) — Other Non Cash Items: 267630.00
DR0.DE balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 2.00
DR0.DE income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -5488660.00
DR0.DE income_statement (annual, 2022-12-31) — Other Operating Expenses: 5123970.00
DR0.DE balance_sheet (annual, 2022-12-31) — Other Properties: 357692303.00
DR0.DE balance_sheet (annual, 2022-12-31) — Other Receivables: 83157.00
DR0.DE balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 6716587.00
DR0.DE income_statement (annual, 2022-12-31) — Other Special Charges: -1328304.00
DR0.DE income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
DR0.DE balance_sheet (annual, 2022-12-31) — Payables: 12605829.00
DR0.DE balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 20462.00
DR0.DE balance_sheet (annual, 2022-12-31) — Prepaid Assets: 862904.00
DR0.DE income_statement (annual, 2022-12-31) — Pretax Income: 85938020.00
DR0.DE balance_sheet (annual, 2022-12-31) — Properties: 32264304.00
DR0.DE cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -6034493.00
DR0.DE cash_flow (annual, 2022-12-31) — Purchase Of Investment: -20089253.00
DR0.DE cash_flow (annual, 2022-12-31) — Purchase Of PPE: -82915052.00
DR0.DE income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 72284870.00
DR0.DE income_statement (annual, 2022-12-31) — Reconciled Depreciation: 39790250.00
DR0.DE cash_flow (annual, 2022-12-31) — Repayment Of Debt: -29438977.00
DR0.DE cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -16358904.00
DR0.DE balance_sheet (annual, 2022-12-31) — Retained Earnings: 84174402.00
DR0.DE cash_flow (annual, 2022-12-31) — Sale Of Intangibles: 6490002.00
DR0.DE cash_flow (annual, 2022-12-31) — Sale Of Investment: 29753831.00
DR0.DE cash_flow (annual, 2022-12-31) — Sale Of PPE: 6490002.00
DR0.DE income_statement (annual, 2022-12-31) — Selling General And Administration: 5872802.00
DR0.DE balance_sheet (annual, 2022-12-31) — Share Issued: 5003081.00
DR0.DE income_statement (annual, 2022-12-31) — Special Income Charges: 823729.00
DR0.DE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 128961442.00
DR0.DE balance_sheet (annual, 2022-12-31) — Tangible Book Value: 95031960.00
DR0.DE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 1834470.37
DR0.DE income_statement (annual, 2022-12-31) — Tax Provision: 19752414.00
DR0.DE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
DR0.DE cash_flow (annual, 2022-12-31) — Taxes Refund Paid: 0.00
DR0.DE balance_sheet (annual, 2022-12-31) — Total Assets: 350326490.00
DR0.DE balance_sheet (annual, 2022-12-31) — Total Capitalization: 238776442.00
DR0.DE balance_sheet (annual, 2022-12-31) — Total Debt: 109892096.00
DR0.DE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 132364871.00
DR0.DE income_statement (annual, 2022-12-31) — Total Expenses: 84536343.00
DR0.DE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 217961619.00
DR0.DE balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 261521001.00
DR0.DE balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 177660037.00
DR0.DE balance_sheet (annual, 2022-12-31) — Total Tax Payable: 1230267.00
DR0.DE income_statement (annual, 2022-12-31) — Total Unusual Items: 7981341.00
DR0.DE income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 7981341.00
DR0.DE balance_sheet (annual, 2022-12-31) — Working Capital: 48503907.00
DR0.DE income_statement (annual, 2022-12-31) — Write Off: 2976797.00
DR0.DE income_statement (annual, 2023-12-31) — +Operating Expense: 17694007.00
DR0.DE income_statement (annual, 2023-12-31) — +Total Revenue: 196650984.00
DR0.DE balance_sheet (annual, 2023-12-31) — Accounts Payable: 26550778.00
DR0.DE balance_sheet (annual, 2023-12-31) — Accounts Receivable: 29603344.00
DR0.DE balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -239773648.00
DR0.DE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 31297014.00
DR0.DE balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 8339534.00
DR0.DE income_statement (annual, 2023-12-31) — Basic Average Shares: 5005767.00
DR0.DE income_statement (annual, 2023-12-31) — Basic EPS: 13.02
DR0.DE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 47402131.00
DR0.DE cash_flow (annual, 2023-12-31) — Capital Expenditure: -198738318.00
DR0.DE balance_sheet (annual, 2023-12-31) — Capital Stock: 5005438.00
DR0.DE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 75807436.00
DR0.DE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 82187744.00
DR0.DE cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -6504469.00
DR0.DE balance_sheet (annual, 2023-12-31) — Cash Financial: 75807436.00
DR0.DE cash_flow (annual, 2023-12-31) — Change In Inventory: -4625717.00
DR0.DE cash_flow (annual, 2023-12-31) — Change In Payable: 2618799.00
DR0.DE cash_flow (annual, 2023-12-31) — Change In Working Capital: -2012224.00
DR0.DE cash_flow (annual, 2023-12-31) — Changes In Cash: 29454997.00
DR0.DE balance_sheet (annual, 2023-12-31) — Common Stock: 5005438.00
DR0.DE cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -6504469.00
DR0.DE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 180371582.00
DR0.DE cash_flow (annual, 2023-12-31) — Common Stock Issuance: 2127250.00
DR0.DE cash_flow (annual, 2023-12-31) — Common Stock Payments: -160363.00
DR0.DE balance_sheet (annual, 2023-12-31) — Construction In Progress: 17005771.00
DR0.DE income_statement (annual, 2023-12-31) — Cost Of Revenue: 97648551.00
DR0.DE balance_sheet (annual, 2023-12-31) — Current Assets: 118453506.00
DR0.DE balance_sheet (annual, 2023-12-31) — Current Debt: 61323209.00
DR0.DE balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 61323209.00
DR0.DE balance_sheet (annual, 2023-12-31) — Current Liabilities: 104932197.00
DR0.DE cash_flow (annual, 2023-12-31) — Deferred Tax: 17419677.00
DR0.DE cash_flow (annual, 2023-12-31) — Depreciation: 63383797.00
DR0.DE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 63383797.00
DR0.DE income_statement (annual, 2023-12-31) — Diluted Average Shares: 5005767.00
DR0.DE income_statement (annual, 2023-12-31) — Diluted EPS: 13.02